Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer
Authors
Keywords
-
Journal
CANCER CELL
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-11-02
DOI
10.1016/j.ccell.2023.10.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
- (2022) Thomas Powles et al. NATURE MEDICINE
- Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function
- (2022) Joshua R. Veatch et al. CANCER CELL
- Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression
- (2021) Sujun Chen et al. NATURE CELL BIOLOGY
- Transcriptional mediators of treatment resistance in lethal prostate cancer
- (2021) Meng Xiao He et al. NATURE MEDICINE
- Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
- (2021) Lauren Brady et al. Nature Communications
- Longitudinal Immune Profiling Reveals Unique Myeloid and T-cell Phenotypes Associated with Spontaneous Immunoediting in a Prostate Tumor Model
- (2021) Casey R Ager et al. Cancer Immunology Research
- How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer
- (2021) Jacob Stultz et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first-line advanced melanoma: Primary phase III results from RELATIVITY-047 (CA224-047).
- (2021) Evan J. Lipson et al. JOURNAL OF CLINICAL ONCOLOGY
- Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment
- (2021) Youmna Kfoury et al. CANCER CELL
- Clinical and biological relevance of the transcriptomic‐based prostate cancer metastasis subtypes MetA‐C
- (2021) Elin Thysell et al. Molecular Oncology
- Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy
- (2020) Jessica E. Hawley et al. PROSTATE
- T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer
- (2020) Aleksandar Z. Obradovic et al. CLINICAL CANCER RESEARCH
- Regenerative potential of prostate luminal cells revealed by single-cell analysis
- (2020) Wouter R. Karthaus et al. SCIENCE
- First‐in‐human phase 1 study of MK‐1248, an anti–glucocorticoid‐induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors
- (2020) Ravit Geva et al. CANCER
- Genomic and phenotypic heterogeneity in prostate cancer
- (2020) Michael C. Haffner et al. Nature Reviews Urology
- Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer
- (2020) Baijun Dong et al. Communications Biology
- Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
- (2019) Dvir Aran et al. NATURE IMMUNOLOGY
- Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
- (2019) Elisabeth Perez-Ruiz et al. NATURE
- Rational design of anti-GITR-based combination immunotherapy
- (2019) Roberta Zappasodi et al. NATURE MEDICINE
- GITR agonism — combination is key
- (2019) David Killock Nature Reviews Clinical Oncology
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- Characterization and comparison of GITR expression in solid tumors
- (2019) Luis Vence et al. CLINICAL CANCER RESEARCH
- The TNF Paradox in Cancer Progression and Immunotherapy
- (2019) Anne Montfort et al. Frontiers in Immunology
- Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
- (2019) Mark P. Labrecque et al. JOURNAL OF CLINICAL INVESTIGATION
- Genomic and clinical characterization of pulmonary‐only metastatic prostate cancer: A unique molecular subtype
- (2019) Eugene Shenderov et al. PROSTATE
- Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor–Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors
- (2019) Kimberley M. Heinhuis et al. JAMA Oncology
- Structure and regulation of human epithelial cell transforming 2 protein
- (2019) Mengran Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer
- (2018) Michael C. Haffner et al. AMERICAN JOURNAL OF PATHOLOGY
- Tumor necrosis factor-α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation
- (2018) Aerken Maolake et al. CANCER SCIENCE
- Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
- (2018) David A. Quigley et al. CELL
- Inhibitors of the PD-1 Pathway in Tumor Therapy
- (2018) Martin W. LaFleur et al. JOURNAL OF IMMUNOLOGY
- A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
- (2018) Mariano J. Alvarez et al. NATURE GENETICS
- Quantitative assessment of protein activity in orphan tissues and single cells using the metaVIPER algorithm
- (2018) Hongxu Ding et al. Nature Communications
- Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses
- (2018) Amanda J. Oliver et al. Frontiers in Immunology
- Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors
- (2018) Ben Tran et al. Journal for ImmunoTherapy of Cancer
- Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model
- (2017) Ying-Chun Shen et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer
- (2017) Yixiang Zhang et al. Oncotarget
- ARACNe-AP: gene network reverse engineering through adaptive partitioning inference of mutual information
- (2016) Alexander Lachmann et al. BIOINFORMATICS
- Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast Cancers
- (2016) Campbell D. Lawson et al. CANCER RESEARCH
- Functional characterization of somatic mutations in cancer using network-based inference of protein activity
- (2016) Mariano J Alvarez et al. NATURE GENETICS
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse
- (2016) Yang Pu et al. Science Translational Medicine
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation
- (2014) Haydn T. Kissick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival
- (2014) Jaya Sharma et al. PROSTATE
- Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
- (2013) Edward Y Chen et al. BMC BIOINFORMATICS
- BLUEPRINT: mapping human blood cell epigenomes
- (2013) J. H. A. Martens et al. HAEMATOLOGICA
- Androgen Regulation of the TMPRSS2 Gene and the Effect of a SNP in an Androgen Response Element
- (2013) Liesbeth Clinckemalie et al. MOLECULAR ENDOCRINOLOGY
- Increased CD8+ T-cell Function following Castration and Immunization Is Countered by Parallel Expansion of Regulatory T Cells
- (2012) S. Tang et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients
- (2010) Carlo Sorrentino et al. CLINICAL CANCER RESEARCH
- Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses
- (2010) Matthew D. Morse et al. HUMAN IMMUNOLOGY
- Inhibiting TNF-mediated signaling: a novel therapeutic paradigm for androgen independent prostate cancer
- (2009) Sowmyalakshmi Srinivasan et al. APOPTOSIS
- CCL2 and Interleukin-6 Promote Survival of Human CD11b+Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization
- (2009) Hernan Roca et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients
- (2009) Philippe O. Gannon et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells
- (2009) J. F. Grosso et al. JOURNAL OF IMMUNOLOGY
- ETS gene fusions in prostate cancer
- (2009) Jeremy P. Clark et al. Nature Reviews Urology
- Human prostate-infiltrating CD8+T lymphocytes are oligoclonal and PD-1+
- (2009) Karen S. Sfanos et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation